Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navaneeth Narayanan

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Pharmacotherapy|December 14, 2017
Disaster Preparedness: Biological Threats and Treatment OptionsNavaneeth Narayanan, Clifton R Lacy, Joseph E Cruz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2024
Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute2Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims StudyMohamed I Elsaid, Tina John, You Li, et al.
Diagnostic Microbiology and Infectious Disease|July 10, 2018
Collaboration between an antimicrobial stewardship team and the microbiology laboratory can shorten time to directed antibiotic therapy for methicillin-susceptible staphylococcal bacteremia and to discontinuation of antibiotics for coagulase-negative staphylococcal contaminantsTanaya Bhowmick, Thomas J Kirn, Frances Hetherington, et al.
Tuberculosis (Edinburgh, Scotland)|November 14, 2022
Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations studyKrina Mehta, Navaneeth Narayanan, Scott K Heysell, et al.
Current Pharmacology Reports|March 31, 2025
Rapid diagnostics to enhance therapy selection for the treatment of bacterial infectionsHaYoung Ryu, Ahmed Abdul Azim, Pinki J Bhatt, et al.
Open Forum Infectious Diseases|March 30, 2022
Safety and Effectiveness of High-Dose Cefazolin in Patients With High Body Weight: A Retrospective Cohort StudyHaYoung Ryu, Sana Mohayya, Thomas Hong, et al.
American Journal of Pharmaceutical Education|December 25, 2019
A Comprehensive Survey of Infectious Diseases Curriculum Among US Pharmacy SchoolsMeghan N Jeffres, Wesley D Kufel, Lauren R Biehle, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 23, 2023
Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremiaSana M Mohayya, Mohammad Arsalan, Navaneeth Narayanan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
The association between undetected heteroresistance and antibiotic treatment failure in complicated urinary tract infectionCarter N Abbott, Aditi Dhillon, Sushma Timalsina, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Pharmacotherapy|December 14, 2017
Disaster Preparedness: Biological Threats and Treatment OptionsNavaneeth Narayanan, Clifton R Lacy, Joseph E Cruz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2024
Amoxicillin-Clavulanate Breakpoints Against Haemophilus influenzae: Rationale for Revision by the Clinical and Laboratory Standards Institute2Navaneeth Narayanan, Amy J Mathers, Eric Wenzler, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims StudyMohamed I Elsaid, Tina John, You Li, et al.
Diagnostic Microbiology and Infectious Disease|July 10, 2018
Collaboration between an antimicrobial stewardship team and the microbiology laboratory can shorten time to directed antibiotic therapy for methicillin-susceptible staphylococcal bacteremia and to discontinuation of antibiotics for coagulase-negative staphylococcal contaminantsTanaya Bhowmick, Thomas J Kirn, Frances Hetherington, et al.
Tuberculosis (Edinburgh, Scotland)|November 14, 2022
Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations studyKrina Mehta, Navaneeth Narayanan, Scott K Heysell, et al.
Current Pharmacology Reports|March 31, 2025
Rapid diagnostics to enhance therapy selection for the treatment of bacterial infectionsHaYoung Ryu, Ahmed Abdul Azim, Pinki J Bhatt, et al.
Open Forum Infectious Diseases|March 30, 2022
Safety and Effectiveness of High-Dose Cefazolin in Patients With High Body Weight: A Retrospective Cohort StudyHaYoung Ryu, Sana Mohayya, Thomas Hong, et al.
American Journal of Pharmaceutical Education|December 25, 2019
A Comprehensive Survey of Infectious Diseases Curriculum Among US Pharmacy SchoolsMeghan N Jeffres, Wesley D Kufel, Lauren R Biehle, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|February 23, 2023
Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremiaSana M Mohayya, Mohammad Arsalan, Navaneeth Narayanan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
The association between undetected heteroresistance and antibiotic treatment failure in complicated urinary tract infectionCarter N Abbott, Aditi Dhillon, Sushma Timalsina, et al.
Pageof 5